Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.00
-0.21 (-6.54%)
At close: Aug 15, 2025, 3:59 PM
3.04
1.32%
After-hours: Aug 15, 2025, 07:53 PM EDT

Bionano Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
28.46M 30.78M 33.33M 36.58M 37.47M 36.12M 33.61M 31.51M 29.52M 27.8M 25.89M 23.32M 20.51M 17.98M 15.67M 13.21M 10.54M
Cost of Revenue
27.5M 30.4M 33.93M 25.98M 27.15M 26.55M 24.68M 23.52M 22.37M 21.86M 21.51M 19.6M 16.82M 14.11M 10.85M 8.81M 7M
Gross Profit
960K 380K -599K 10.6M 10.32M 9.56M 8.93M 7.99M 7.16M 5.95M 4.38M 3.73M 3.69M 3.88M 4.81M 4.4M 3.54M
Operating Income
-81.33M -99.99M -108.08M -177.4M -199.62M -210.33M -227.82M -146.76M -139.6M -131.7M -122.95M -111.48M -95.88M -77.1M -59.44M -48.99M -39.95M
Interest Income
1.35M 2.1M 3.07M 3.42M 3.65M 3.31M 2.89M 2.6M 2.1M 1.51M 974K 567K 433K 388K 152K 123K 65K
Pretax Income
-83.64M -111.98M -135.79M -204.09M -226.77M -232.43M -225.38M -144.63M -137.87M -130.71M -122.56M -111.49M -98.15M -78.15M -61.17M -51.21M -40.5M
Net Income
-83.7M -112.02M -135.78M -204.1M -226.79M -232.49M -227.28M -146.52M -139.77M -132.6M -116.87M -105.81M -92.44M -72.44M -61.22M -51.26M -40.54M
Selling & General & Admin
41.8M 52.94M 51.97M 67.4M 82.78M 88.58M 103.13M 99.45M 94.3M 88.6M 83.08M 77.19M 69.24M 58.49M 48.11M 41.44M 33.23M
Research & Development
17.39M 24.8M 33.03M 42.1M 49.88M 54.03M 56.34M 55.3M 52.46M 49.05M 44.25M 38.01M 30.33M 22.48M 16.15M 11.94M 10.26M
Other Expenses
22.63M 22.63M 22.49M 1.24M -230K -230K -270K -291K -191K -224K -147K -219K -78K -60K -97K 24K -34K
Operating Expenses
81.82M 100.37M 107.48M 110.71M 132.65M 142.61M 159.47M 154.75M 146.75M 137.64M 127.33M 115.21M 99.57M 80.97M 64.26M 53.39M 43.49M
Interest Expense
180K 217K 5.09M 5.09M 5.17M 5.12M 296K 298K 298K 299K 430K 359K 553K 1.08M 1.48M 2.07M 2.36M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 802.00 802.00 802.00
Cost & Expenses
109.32M 130.77M 141.42M 136.69M 159.81M 169.16M 184.15M 178.27M 169.12M 159.5M 148.84M 134.81M 116.39M 95.08M 75.11M 62.2M 50.49M
Income Tax Expense
44K 33K -4K 11K 18K 62K 1.9M 1.89M 1.9M 1.88M -5.69M -5.68M -5.71M -5.72M 39.19K 34.19K 30.19K
Shares Outstanding (Basic)
2.69M 1.9M 1.46M 1.15M 890.29K 676.6K 595.02K 535.47K 513.1K 504.82K 492.49K 485.44K 483.84K 482.72K 476.3K 456.23K 448.7K
Shares Outstanding (Diluted)
2.69M 1.9M 1.46M 1.15M 896.56K 677.66K 595.02K 535.47K 513.49K 504.82K 492.49K 485.44K 483.84K 482.72K 476.3K 474.13K 448.7K
EPS (Basic)
-3.31K -5.46K -8.77K -18.55K -22.13K -24.41K -25.14K -17.51K -17.12K -16.48K -14.7K -13.42K -11.79K -9.36K -10.5K -10.75K -11.53K
EPS (Diluted)
-3.31K -5.47K -8.79K -18.57K -22.16K -24.42K -25.14K -17.52K -17.12K -16.48K -14.7K -13.42K -11.88K -9.45K -10.59K -10.85K -11.53K
EBITDA
-77.3M -97.09M -114.88M -185.24M -208.13M -213.65M -212.15M -132.6M -126.74M -120.58M -112.68M -103.59M -91.9M -73.23M -57.77M -47.48M -36.64M
EBIT
-80.05M -111.37M -130.3M -198.61M -221.61M -227.31M -225.08M -144.33M -137.57M -130.41M -122.52M -111.53M -98.06M -77.59M -59.82M -49.33M -38.27M
Depreciation & Amortization
11.17M 14.23M 15.37M 13.32M 13.48M 13.67M 12.93M 11.73M 10.83M 10.1M 9.72M 7.82M 6.03M 3.97M 2.06M 1.85M 1.63M